0001213900-22-077730.txt : 20221206
0001213900-22-077730.hdr.sgml : 20221206
20221205192532
ACCESSION NUMBER: 0001213900-22-077730
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20221206
DATE AS OF CHANGE: 20221205
EFFECTIVENESS DATE: 20221206
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-466617
FILM NUMBER: 221446327
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
D
1
primary_doc.xml
X0708
D
LIVE
0001728328
InMed Pharmaceuticals Inc.
815 W. HASTINGS STREET
SUITE 310
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
(604) 669-7207
BRITISH COLUMBIA, CANADA
None
None
Corporation
true
Eric
A.
Adams
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Director
Sarah
Li
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Alexandra
D.J.
Mancini
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Michael
Woudenberg
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
William
J.
Garner
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Janet
Grove
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Andrew
Hull
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Bryan
Baldasare
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Nicole
Lemerond
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Eric
C.
Hsu
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-11-21
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE
4TH FLOOR
NEW YORK
NY
NEW YORK
10022
All States
false
6000177
6000177
0
Consists of (i) $6,000,010.50 received and (ii) approximately $166.82 to be received upon exercise of pre-funded warrants sold in the offering to purchase up to an aggregate of 1,668,185 common shares at an exercise price of $0.0001 per share.
false
2
450000
0
In addition to the $450,000, the issuer paid to the sole placement agent in the offering, a management fee of $60,000, $20,000 for non-accountable expenses and $35,000 for fees and expenses of legal counsel and other out-of-pocket expenses.
0
false
InMed Pharmaceuticals Inc.
/s/ Eric A. Adams
Eric A. Adams
President and Chief Executive Officer
2022-12-01